BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 26.30
-0.70 (-2.59%)
At close: Jun 22, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 153.39 million as of June 22, 2026. Its market cap has decreased by -26.22% in one year.
Market Cap
153.39M
Enterprise Value
92.61M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.30
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 153.39M, a decrease of -26.23%. That is a compound annual growth rate of -19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 153.39M | 7.50% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.09B |
| Idorsia | 1.45B |
| Basilea Pharmaceutica AG | 635.91M |
| Newron Pharmaceuticals | 253.83M |
| Santhera Pharmaceuticals Holding AG | 236.47M |
| Xlife Sciences AG | 143.70M |
| Molecular Partners AG | 115.91M |
| MindMaze Therapeutics Holding | 32.89M |